Topical tretinoin (single-entity and combination) coverage
Defines Cigna's prior authorization recommendations and medical necessity criteria for coverage of single-entity and combination topical tretinoin products for FDA-indicated and select non-cosmetic uses; applies to Cigna-administered health benefit plans.
The 'Treatment of Other Non-Cosmetic Conditions' note was revised and multiple conditions were added, clarified, renamed, or removed.
Under Cosmetic Conditions, the note was clarified that the list of examples is not all-inclusive and additional cosmetic examples were added or deleted.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.